Cytosystems Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 8
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $511K
Latest Deal Amount
  • Investors
  • 4

Cytosystems General Information

Description

Developer of non-invasive diagnostic and stratification technologies designed to detect cancer varieties. The company's technologies focus on the diagnosis and prognosis of urological cancers, including bladder and prostate cancer, and deploys highly sensitive and specific antibody diagnostic, enabling medical practitioners to simple, inexpensive and reliable alternatives to cystoscopies and other traditional invasive approaches.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • The James Hutton Institute
  • Craigiebuckler
  • Aberdeen AB15 8QH
  • Scotland, United Kingdom
+44 01224 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cytosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 13-Dec-2018 $511K 00.000 00.000 Completed Generating Revenue
8. Grant 19-Jul-2016 00000 00.000 Completed Generating Revenue
7. Grant 01-Jun-2015 00.000 00.000 Completed Generating Revenue
6. Secondary Transaction - Private 18-Jul-2013 00.000 Completed Startup
5. Early Stage VC 23-Jul-2012 00000 00.000 00.000 Completed Startup
4. Early Stage VC 19-Sep-2011 00000 00.000 00.00 Completed Startup
3. Early Stage VC 06-Oct-2009 00.000 00.000 00.000 Completed Startup
2. Early Stage VC 31-Jan-2007 Completed Startup
1. Early Stage VC 25-Nov-2006 Completed Startup
To view Cytosystems’s complete valuation and funding history, request access »

Cytosystems Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
D Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
D Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
D Ordinary 00,000 00.000000 00.00 00.00 00 00.00 0.000
D Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Pref 000 00.000000 000.00 000.00 00 000.00 0.000
D Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
D Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
E Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
D Ordinary 1,239 $0.012766 $165.37 $165.37 1x $165.37 0.19%
C Ordinary 477 $0.012766 $165.37 $165.37 1x $165.37 0.07%
To view Cytosystems’s complete cap table history, request access »

Cytosystems Patents

Cytosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-2543660-B Filtration apparatus comprising two movable ports moved from a first to second position thrugh rotation of the membrane housing Active 19-Oct-2015 00000000
GB-201617256-D0 Filtration apparatus Granted 19-Oct-2015 00000000
CA-3039947-A1 Filtration apparatus Pending 19-Oct-2015 00000000
EP-3365654-A2 Filtration apparatus Pending 19-Oct-2015 00000000
GB-2543660-A Filtration apparatus Granted 19-Oct-2015 G01N1/18

Cytosystems Executive Team (3)

Name Title Board Seat Contact Info
Richard Berry Chief Executive Officer & Board Member
David Galloway Ph.D Founder & Medical and Scientific Director
You’re viewing 2 of 3 executive team members. Get the full list »

Cytosystems Board Members (3)

Name Representing Role Since
Nadir Mahjoub Self Board Member 000 0000
Richard Berry Cytosystems Chief Executive Officer & Board Member 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Cytosystems Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cytosystems Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Horizon 2020 Government 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Cancer Research UK Venture Capital Minority 000 0000 000000 0
Scottish Enterprise Venture Capital Minority 000 0000 000000 0
To view Cytosystems’s complete investors history, request access »